CPT2 and colon adenocarcinoma: While low expression of SUCLG2 (Figure 10E, p < 0.001), PTGR1 (Figure 10F, p = 0.001), ELOVL6 (Figure 10G, p = 0.013) and CPT2 (Figure 10H, p < 0.001) were correlated with poor overall survival of colon adenocarcinoma patients.